Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1963 Sep 28;89(13):633–641.

Effect of an Aldosterone Antagonist (Spironolactone) on Patients with Severe Congestive Heart Failure

B M Carruthers, R D Ledray, M Seraglia, H W McIntosh, M M Baird, G C Walsh
PMCID: PMC1921971  PMID: 14077808

Abstract

Spironolactone was evaluated as a diuretic in the therapy of six patients with chronic severe congestive heart failure, during which metabolic balance studies were performed. Two of the patients showed a clear-cut although moderate diuresis and natriuresis in response to spironolactone in the presence of other diuretics. Two patients had slight unsustained responses and two showed no response. No significant change in potassium excretion was observed. A decrease in the serum sodium level was noted in four patients, associated with a rise in serum potassium. Urinary aldosterone excretion was normal or low in all patients and showed no correlation with the diuretic response to spironolactone.

It is concluded that spironolactone has definite but limited usefulness in the therapy of some but not all patients with chronic congestive heart failure.

Full text

PDF
633

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUGUST J. T., NELSON D. H., THORN G. W. Aldosterone. N Engl J Med. 1958 Nov 13;259(20):967–concl. doi: 10.1056/NEJM195811132592005. [DOI] [PubMed] [Google Scholar]
  2. BARTTER F. C., DUNCAN L. E., Jr, LIDDLE G. W. The effect of changes in body sodium on extracellular fluid volume and aldosterone and sodium excretion by normal and edematous men. J Clin Invest. 1956 Nov;35(11):1299–1305. doi: 10.1172/JCI103385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. EDMONDS C. J. An aldosterone antagonist and diuretics in the treatment of chronic oedema and ascites. Lancet. 1960 Mar 5;1(7123):509–515. doi: 10.1016/s0140-6736(60)90448-7. [DOI] [PubMed] [Google Scholar]
  4. GENEST J., JONES R. N., KOIW E., NOWACZYNSKI W. J., STEYERMARK P. R. Detailed study of a purified urinary aldosterone fraction. Can J Biochem Physiol. 1956 Sep;34(5):1023–1038. [PubMed] [Google Scholar]
  5. MULLER A. F. [Aldosterone and edema. Physiopathology of hyperaldosteronuria in lipoid nephrosis and cardiac insufficiency]. Schweiz Med Wochenschr. 1959 Oct 17;89:1093–1101. [PubMed] [Google Scholar]
  6. Merrill A. J. EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA. J Clin Invest. 1946 May;25(3):389–400. doi: 10.1172/JCI101720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SINGER B., WENER J. Excretion of sodium-retaining substances in patients with congestive heart failure. Am Heart J. 1953 Jun;45(6):795–801. doi: 10.1016/0002-8703(53)90127-6. [DOI] [PubMed] [Google Scholar]
  8. ULICK S., LARAGH J. H., LIEBERMAN S. The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man. Trans Assoc Am Physicians. 1958;71:225–235. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES